RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 271 - per page Next page
Order by
Bayer/Johnson & Johnson's Xarelto will drive the anticoagulant drug market to more than double by 2016
Market potential for new oral agents is highest in prevention of stroke in patients with Atrial Fibrillation, according to a new report from Decision Resources More
Bayer Schering/Johnson & Johnson's Rivaroxaban will overtake Glaxosmithkline's Arixtra as the clinical gold standard for the Treatment of Venous Thromboembolism by 2010
Competition from Eli Lilly will challenge Rivaroxaban by 2015, according to a new report from Decision Resources More
Driven by Genentech/Roche/Chugai's Avastin, the Ovarian Cancer drug market will more than triple to US$1.6 billion by 2016
Key unmet needs will be addressed by novel treatment options that include Marshall Edwards' Phenoxodiol and Virexx's Ovarex, according to a new report from Decision Resources More
Physicians are not yet ready to use Januvia or Byetta as a replacement for Avandia; instead, they will use the agents as 2nd- & 3rd-line options in the treatment of Type 2 Diabetes
Private managed care organizations are more likely to provide formulary coverage for Byetta than for Januvia, according to a new report from Decision Resources More
Eli Lilly to become Osteoporosis market leader by 2011, despite lacking a Bisphosphonate in its portfolio
Leadership position in the Osteoporosis market is driven by differentiation, according to a new report from Decision Resources More
Newly Created Hemosol BioPharma Inc. on the Hunt for Partnership, Licensing and Acquisition Targets
Newly Created Hemosol BioPharma Inc. on the Hunt for Partnership, Licensing and Acquision Targets More
Sanofi-Aventis's Taxotere will lead the Taxane market through 2010, but generic erosion of the drug will reduce overall market value by 2015
Efficacy plateau of Taxanes will allow only modest commercial rewards for Novel Taxanes, according to a new report from Decision Resources More
APR Applied Pharma Research s.a. has successfully completed the development of Veloderm, an innovative biotech wound dressing and transferred the worldwide marketing rights to Medestea Internazionale.
APR has successfully designed and completed the development of Veloderm, an innovative Biotechnology device for wound healing and licensed to Medestea the exclusive worldwide marketing rights More
Sepracor's Lunesta will dominate market share in the Insomnia market by 2010
Sanofi-Aventis will attempt to remain a leading player in the market, according to a new report from Decision Resources More
Alcon's AcrySof® ReSTOR® Apodized Diffractive Aspheric Intraocular Lens Approved by FDA
Alcon's AcrySof® ReSTOR® Apodized Diffractive Aspheric Intraocular Lens Approved by FDA More
Displaying 1..10 of 271 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
UK Aftermarket - Batteries Data Report to 2012
Apr 2008 - 21 pages - $1,295
UK Aftermarket - Tyres Data Report to 2012
Apr 2008 - 19 pages - $1,295
UK Aftermarket - Filters Data Report to 2012
Apr 2008 - 21 pages - $1,295
UK Aftermarket - Exhausts Data Report to 2012
Apr 2008 - 18 pages - $1,295
Automotive Aftermarket Overview and Products in the UK to 2012
Apr 2008 - 38 pages - $2,295
Vodafone Group HSDPA strategy
Feb 2007 - 20 pages - $1,100
Germany Aftermarket - Batteries Data Report to 2012
Apr 2008 - 18 pages - $1,295
Germany Aftermarket - Filters Data Report to 2012
Apr 2008 - 20 pages - $1,295
Italy Aftermarket - Filters Data Report to 2012
Apr 2008 - 20 pages - $1,295
France Aftermarket - Filters Data Report to 2012
Apr 2008 - 21 pages - $1,295
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us